Literature DB >> 8925077

Identification of flavonoid metabolites after oral administration to rats of a Ginkgo biloba extract.

P G Pietta1, C Gardana, P L Mauri, R Maffei-Facino, M Carini.   

Abstract

An extract of Ginkgo biloba leaves (EGb) was administered by gastric probe to Wistar female rats, and urine and faeces samples were collected for 5 days and whole blood samples were withdrawn every 30 min for 6 h. After purification with SPE C18 cartridges, the samples were analysed by reversed-phase LC-diode array detection (LC-DAD) for residual flavonoid glycosides, aglycones and metabolites. No glycosides or aglycones were detected in urine, faeces or blood and extensive degradation of EGb flavonoids within 24 h was detected. Among the seven different phenylalkyl acids detected by LC-DAD, 3,4-dihydroxyphenylacetic acid (I), hippuric acid (II), 3-hydroxyphenylacetic acid (III), homovanillic acid (IV) and benzoic acid (VII) were directly confirmed by on-line mass spectrometry using an electrospray interface (ES-MS). Peaks V and VI needed to be collected and separately examined and they were found to be 3-(4-hydrophenyl)propionic acid and 3-(3-hydrophenyl)propionic acid, respectively. As further evidence, the identity of metabolites I, II, III, IV, V and VII was confirmed by co-chromatography with authentic standards.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8925077     DOI: 10.1016/0378-4347(95)00252-e

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  2 in total

1.  Systemic exposure to Ginkgo biloba extract in male F344/NCrl rats: Relevance to humans.

Authors:  Suramya Waidyanatha; Esra Mutlu; Seth Gibbs; Billie Stiffler; Jon Andre; Brian Burback; Cynthia V Rider
Journal:  Food Chem Toxicol       Date:  2019-06-14       Impact factor: 6.023

Review 2.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.